Role of suilysin in pathogenesis of Streptococcus suis capsular serotype 2

Shichun Lun, Jose Perez-Casal, Wayne Connor, P. J. Willson

Research output: Contribution to journalArticle

Abstract

Three suilysin (SLY) knockout mutant strains of Streptococcus suis serotype 2 were generated by allelic replacement from one North American and two European wild type strains. The mutants were characterized by Southern blot, Western blot and phenotyping. In vitro bactericidal testing showed that both wild type and SLY mutants were resistant to bactericidal factors in whole pig blood. To demonstrate the role of SLY during S. suis infection, four animal trials were carried out using young pigs. Either high dose (4×106CFU/ml/pig) or low dose (0.5×106CFU/ml/pig) live cell aerosol was applied to the pharynx. In one trial, a low challenge dose of North American strain SX332 and its isogenic sly- mutant strain (SX932) resulted in acute disease in 3/5 of pigs exposed to the wild type strain, while 5/5 of pigs exposed to the mutant strain survived the trial. In the repeat trial, 1/8 of pigs in wild type group and 6/8 of pigs in mutant group developed disease. The high dose trial with 332/932 pair showed that 4/8 pigs challenged with wild type and 5/8 of pigs challenged with mutant strain developed disease respectively. The third low dose trial, using European strain 31533 and its isogenic sly- mutant strain SX911, showed that 1/8 of pigs challenged with the wild type strain and 4/8 of pigs challenged with the corresponding mutant strain developed disease. All the diseased pigs showed fever, clinical signs and developed septicemia. S. suis was isolated from tissue samples such as brain, submandibular lymph node, lung, spleen, liver, heart or joint. Serum antibody titer against cell surface proteins changed little while the antibody titer against SLY increased only in the wild type group after challenge. sly gene was cloned and expressed in E. coli. The recombinant SLY (rSLY) protein showed 800 hemolysin units per μg protein. In vitro study showed that rSLY triggered TNFα production by human monocytes and IL-6 production by pig pulmonary alveolar macrophages and monocytes. Thus, the results of this study suggest that SLY does not seem to be a critical virulence factor for S. suis serotype 2 respiratory infection, but by stimulating cytokine release it may play a role in innate immunity.

Original languageEnglish (US)
Pages (from-to)27-37
Number of pages11
JournalMicrobial Pathogenesis
Volume34
Issue number1
DOIs
StatePublished - Jan 1 2003
Externally publishedYes

Fingerprint

Streptococcus suis
Swine
Alveolar Macrophages
Serogroup
suilysin
Monocytes
Hemolysin Proteins
Antibodies
Acute Disease
Virulence Factors

Keywords

  • Aerosol challenge
  • Bactericidal test
  • Cytokine production
  • Pig model
  • Streptococcus suis
  • Suilysin

ASJC Scopus subject areas

  • Microbiology
  • Infectious Diseases

Cite this

Role of suilysin in pathogenesis of Streptococcus suis capsular serotype 2. / Lun, Shichun; Perez-Casal, Jose; Connor, Wayne; Willson, P. J.

In: Microbial Pathogenesis, Vol. 34, No. 1, 01.01.2003, p. 27-37.

Research output: Contribution to journalArticle

Lun, Shichun ; Perez-Casal, Jose ; Connor, Wayne ; Willson, P. J. / Role of suilysin in pathogenesis of Streptococcus suis capsular serotype 2. In: Microbial Pathogenesis. 2003 ; Vol. 34, No. 1. pp. 27-37.
@article{13b70b8a193f4557ad145802a6a7bcef,
title = "Role of suilysin in pathogenesis of Streptococcus suis capsular serotype 2",
abstract = "Three suilysin (SLY) knockout mutant strains of Streptococcus suis serotype 2 were generated by allelic replacement from one North American and two European wild type strains. The mutants were characterized by Southern blot, Western blot and phenotyping. In vitro bactericidal testing showed that both wild type and SLY mutants were resistant to bactericidal factors in whole pig blood. To demonstrate the role of SLY during S. suis infection, four animal trials were carried out using young pigs. Either high dose (4×106CFU/ml/pig) or low dose (0.5×106CFU/ml/pig) live cell aerosol was applied to the pharynx. In one trial, a low challenge dose of North American strain SX332 and its isogenic sly- mutant strain (SX932) resulted in acute disease in 3/5 of pigs exposed to the wild type strain, while 5/5 of pigs exposed to the mutant strain survived the trial. In the repeat trial, 1/8 of pigs in wild type group and 6/8 of pigs in mutant group developed disease. The high dose trial with 332/932 pair showed that 4/8 pigs challenged with wild type and 5/8 of pigs challenged with mutant strain developed disease respectively. The third low dose trial, using European strain 31533 and its isogenic sly- mutant strain SX911, showed that 1/8 of pigs challenged with the wild type strain and 4/8 of pigs challenged with the corresponding mutant strain developed disease. All the diseased pigs showed fever, clinical signs and developed septicemia. S. suis was isolated from tissue samples such as brain, submandibular lymph node, lung, spleen, liver, heart or joint. Serum antibody titer against cell surface proteins changed little while the antibody titer against SLY increased only in the wild type group after challenge. sly gene was cloned and expressed in E. coli. The recombinant SLY (rSLY) protein showed 800 hemolysin units per μg protein. In vitro study showed that rSLY triggered TNFα production by human monocytes and IL-6 production by pig pulmonary alveolar macrophages and monocytes. Thus, the results of this study suggest that SLY does not seem to be a critical virulence factor for S. suis serotype 2 respiratory infection, but by stimulating cytokine release it may play a role in innate immunity.",
keywords = "Aerosol challenge, Bactericidal test, Cytokine production, Pig model, Streptococcus suis, Suilysin",
author = "Shichun Lun and Jose Perez-Casal and Wayne Connor and Willson, {P. J.}",
year = "2003",
month = "1",
day = "1",
doi = "10.1016/S0882-4010(02)00192-4",
language = "English (US)",
volume = "34",
pages = "27--37",
journal = "Microbial Pathogenesis",
issn = "0882-4010",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Role of suilysin in pathogenesis of Streptococcus suis capsular serotype 2

AU - Lun, Shichun

AU - Perez-Casal, Jose

AU - Connor, Wayne

AU - Willson, P. J.

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Three suilysin (SLY) knockout mutant strains of Streptococcus suis serotype 2 were generated by allelic replacement from one North American and two European wild type strains. The mutants were characterized by Southern blot, Western blot and phenotyping. In vitro bactericidal testing showed that both wild type and SLY mutants were resistant to bactericidal factors in whole pig blood. To demonstrate the role of SLY during S. suis infection, four animal trials were carried out using young pigs. Either high dose (4×106CFU/ml/pig) or low dose (0.5×106CFU/ml/pig) live cell aerosol was applied to the pharynx. In one trial, a low challenge dose of North American strain SX332 and its isogenic sly- mutant strain (SX932) resulted in acute disease in 3/5 of pigs exposed to the wild type strain, while 5/5 of pigs exposed to the mutant strain survived the trial. In the repeat trial, 1/8 of pigs in wild type group and 6/8 of pigs in mutant group developed disease. The high dose trial with 332/932 pair showed that 4/8 pigs challenged with wild type and 5/8 of pigs challenged with mutant strain developed disease respectively. The third low dose trial, using European strain 31533 and its isogenic sly- mutant strain SX911, showed that 1/8 of pigs challenged with the wild type strain and 4/8 of pigs challenged with the corresponding mutant strain developed disease. All the diseased pigs showed fever, clinical signs and developed septicemia. S. suis was isolated from tissue samples such as brain, submandibular lymph node, lung, spleen, liver, heart or joint. Serum antibody titer against cell surface proteins changed little while the antibody titer against SLY increased only in the wild type group after challenge. sly gene was cloned and expressed in E. coli. The recombinant SLY (rSLY) protein showed 800 hemolysin units per μg protein. In vitro study showed that rSLY triggered TNFα production by human monocytes and IL-6 production by pig pulmonary alveolar macrophages and monocytes. Thus, the results of this study suggest that SLY does not seem to be a critical virulence factor for S. suis serotype 2 respiratory infection, but by stimulating cytokine release it may play a role in innate immunity.

AB - Three suilysin (SLY) knockout mutant strains of Streptococcus suis serotype 2 were generated by allelic replacement from one North American and two European wild type strains. The mutants were characterized by Southern blot, Western blot and phenotyping. In vitro bactericidal testing showed that both wild type and SLY mutants were resistant to bactericidal factors in whole pig blood. To demonstrate the role of SLY during S. suis infection, four animal trials were carried out using young pigs. Either high dose (4×106CFU/ml/pig) or low dose (0.5×106CFU/ml/pig) live cell aerosol was applied to the pharynx. In one trial, a low challenge dose of North American strain SX332 and its isogenic sly- mutant strain (SX932) resulted in acute disease in 3/5 of pigs exposed to the wild type strain, while 5/5 of pigs exposed to the mutant strain survived the trial. In the repeat trial, 1/8 of pigs in wild type group and 6/8 of pigs in mutant group developed disease. The high dose trial with 332/932 pair showed that 4/8 pigs challenged with wild type and 5/8 of pigs challenged with mutant strain developed disease respectively. The third low dose trial, using European strain 31533 and its isogenic sly- mutant strain SX911, showed that 1/8 of pigs challenged with the wild type strain and 4/8 of pigs challenged with the corresponding mutant strain developed disease. All the diseased pigs showed fever, clinical signs and developed septicemia. S. suis was isolated from tissue samples such as brain, submandibular lymph node, lung, spleen, liver, heart or joint. Serum antibody titer against cell surface proteins changed little while the antibody titer against SLY increased only in the wild type group after challenge. sly gene was cloned and expressed in E. coli. The recombinant SLY (rSLY) protein showed 800 hemolysin units per μg protein. In vitro study showed that rSLY triggered TNFα production by human monocytes and IL-6 production by pig pulmonary alveolar macrophages and monocytes. Thus, the results of this study suggest that SLY does not seem to be a critical virulence factor for S. suis serotype 2 respiratory infection, but by stimulating cytokine release it may play a role in innate immunity.

KW - Aerosol challenge

KW - Bactericidal test

KW - Cytokine production

KW - Pig model

KW - Streptococcus suis

KW - Suilysin

UR - http://www.scopus.com/inward/record.url?scp=0037215998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037215998&partnerID=8YFLogxK

U2 - 10.1016/S0882-4010(02)00192-4

DO - 10.1016/S0882-4010(02)00192-4

M3 - Article

C2 - 12620382

AN - SCOPUS:0037215998

VL - 34

SP - 27

EP - 37

JO - Microbial Pathogenesis

JF - Microbial Pathogenesis

SN - 0882-4010

IS - 1

ER -